Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
News Release
Pennsylvania House Passes Drug Formulary Bill
By Brian Allen, VP of Government Affairs
Workers' Comp
Article
StateWatch: Bill Review April 2018
Keep current with new legislation and its potential effect on your organization.
Workers' Comp
Article
What’s BIG Diversity?
It’s mid-April, a time when my Outlook calendar begins to beep repeatedly in anticipation of the annual RIMS conference.
Mitchell
News Release
Texas Publishes Final Drug Formulary Rule Change
By Brian Allen, VP of Government Affairs
Mitchell
News Release
West Virginia Governor Signs Opioid Reduction Act
In 2016, West Virginia had the
Mitchell
Article
January 2018 Used Vehicle Market Conditions
Current Used Vehicle Market Conditions January 2018 Used Vehicle Market Conditions